A team of Massachusetts General Hospital researchers has found a significant limitation to the use of CRISPR-Cas RGNs, production of unwanted DNA mutations at sites other than the desired target, which indicates a need to improve the specificity of the nucleases.
Fuente : http://www.eurekalert.org/pub_releases/2013-06/mgh...
Fuente : http://www.eurekalert.org/pub_releases/2013-06/mgh...